3 results match your criteria: "The Xiangya Hospital Central South University[Affiliation]"
The significance of guiding anterior cruciate ligament revision: a modified femoral tunnel classification.
BMC Musculoskelet Disord
September 2024
Department of Joint Surgery, The Hebei Medical University Third Hospital, Shijiazhuang City, Hebei Province, 050051, China.
Article Synopsis
- The study investigates the impact of femoral tunnel positioning errors on the success of ACL reconstruction and introduces a new classification system for femoral tunnels to assist in revision surgeries.
- A total of 150 patients with failed ACL reconstructions were analyzed, leading to the development of four femoral tunnel types based on specific imaging criteria and reliability assessments among different groups of doctors.
- Results indicated that the classification system was effective, demonstrating high inter-observer and intra-observer reliability, with some patients showing improved knee function after surgical intervention.
A bibliometric analysis of 23,492 publications on rectal cancer by machine learning: basic medical research is needed.
Therap Adv Gastroenterol
July 2020
Department of Gastrointestinal Surgery, The Xiangya Hospital Central South University, Xiangya Road 110#, Changsha, Hunan 410008, China.
Background And Aims: The aim of this study was to analyse the landscape of publications on rectal cancer (RC) over the past 25 years by machine learning and semantic analysis.
Methods: Publications indexed in PubMed under the Medical Subject Headings (MeSH) term 'Rectal Neoplasms' from 1994 to 2018 were downloaded in September 2019. R and Python were used to extract publication date, MeSH terms and abstract from the metadata of each publication for bibliometric assessment.
Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial.
BMC Complement Altern Med
September 2016
Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No.5 Haiyun Cang, Dong Cheng District, Beijing, China.
Background: The primary objective of this study was to assess whether Zhengtian Capsule was non-inferior to flunarizine in efficacy and safety profile for prevention of migraine in adults.
Methods: This was a double-dummy, double-blind, multicenter, positive drug (flunarizine), parallel randomized controlled, non-inferior clinical trial. Patients (n = 360) were randomized in a 1:1 to receive either Zhengtian Capsule or flunarizine, including 12 weeks' intervention and 4 weeks' follow-up.